Photocatalytic intermolecular bromonitroalkylation of styrenes: synthesis of cyclopropylamine derivatives and their evaluation as LSD1 inhibitors

被引:2
|
作者
Kim, Darong [1 ]
Jeon, Hui-Jeon [1 ]
Kwak, Yoonna [1 ]
Lee, Sun Joo [1 ]
Nam, Tae-Gyu [2 ]
Yu, Ji Hoon [1 ]
An, Hongchan [3 ]
Hong, Ki Bum [1 ]
机构
[1] Daegu Gyeongbuk Med Innovat Fdn DGMIF, New Drug Dev Ctr NDDC, 80 Cheombok Ro, Daegu 41061, South Korea
[2] Hanyang Univ ERICA, Inst Pharmaceut Sci & Technol, Coll Pharm, Dept Pharm, Ansan 15588, Gyeonggi, South Korea
[3] CHA Univ, Inst Pharmaceut Sci, Coll Pharm, 120 Haeryong Ro, Pochon 11160, Gyeonggido, South Korea
基金
新加坡国家研究基金会;
关键词
Bromine compounds - Cyclization - Styrene;
D O I
10.1039/d3ra07830b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A mild and efficient method for photoredox-catalyzed bromonitroalkylation of alkenes is described herein. In this reaction, bromonitromethane serves as a source of both nitroalkyl and bromine for direct and regioselective formation of C-Br and C-C bonds from alkenes, and additional cyclization provides C-C bonds to the cyclopropylamine core as an LSD1 inhibitor. A mild and efficient method for photoredox-catalyzed bromonitroalkylation of alkenes is described herein.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 50 条
  • [31] Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis
    Cuong Quang Le
    Myers, Greggory
    Habara, Alawi
    Jearawiriyapaisarn, Natee
    Murphy, George J.
    Chui, David H. K.
    Steinberg, Martin H.
    Engel, James Douglas
    Cui, Shuaiying
    BLOOD, 2019, 133 (22) : 2455 - 2459
  • [32] Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments
    Hitchin, James R.
    Blagg, Julian
    Burke, Rosemary
    Burns, Samantha
    Cockerill, Mark J.
    Fairweather, Emma E.
    Hutton, Colin
    Jordan, Allan M.
    McAndrew, Craig
    Mirza, Amin
    Mould, Daniel
    Thomson, Graeme J.
    Waddell, Ian
    Ogilvie, Donald J.
    MEDCHEMCOMM, 2013, 4 (11) : 1513 - 1522
  • [33] New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation
    Liang, Liyun
    Wang, Haiwen
    Du, Yongliang
    Luo, Bingling
    Meng, Ning
    Cen, Meifeng
    Huang, Peng
    Ganesan, A.
    Wen, Shijun
    BIOORGANIC CHEMISTRY, 2020, 99
  • [34] Discovery of acridine-based LSD1 inhibitors as immune activators targeting LSD1 in gastric cancer
    Liu, Hui -Min
    Xiong, Xiao-Peng
    Wu, Jiang-Wan
    Chen, He-Xiang
    Zhou, Ying
    Ji, Shi-Kun
    Dai, Xing-Jie
    Zheng, Yi-Chao
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 251
  • [35] Antitumor activity of LSD1 inhibitors in lung cancer
    Mohammad, Helai P.
    Kruger, Ryan G.
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)
  • [36] Natural products as LSD1 inhibitors for cancer therapy
    Fang, Yuan
    Yang, Chao
    Yu, Zhiqiang
    Li, Xiaochuan
    Mu, Qingchun
    Liao, Guochao
    Yu, Bin
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (03) : 621 - 631
  • [37] Natural products as LSD1 inhibitors for cancer therapy
    Yuan Fang
    Chao Yang
    Zhiqiang Yu
    Xiaochuan Li
    Qingchun Mu
    Guochao Liao
    Bin Yu
    Acta Pharmaceutica Sinica B, 2021, 11 (03) : 621 - 631
  • [38] LSD1 inhibitors from the roots of Pueraria lobata
    Tian, Meng-Ru
    Du, Kun
    Zhi, Yan-Le
    Xue, Gui-Min
    Zhao, Zhen-Zhu
    Si, Ying-Ying
    Chen, Hui
    Sun, Yan-Jun
    Feng, Wei-Sheng
    Ma, Jin-Lian
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2023, 25 (01) : 44 - 52
  • [39] Advances toward LSD1 inhibitors for cancer therapy
    Fu, Xiaoli
    Zhang, Peng
    Yu, Bin
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (11) : 1227 - 1242
  • [40] Design, Synthesis, and Biological Evaluation of Potent EZH2/LSD1 Dual Inhibitors for Prostate Cancer
    Le, Meiling
    Lu, Wenhua
    Tan, Xiaozhuo
    Luo, Bingling
    Yu, Tiantian
    Sun, Yameng
    Guo, Zhirong
    Huang, Peng
    Zhu, Daqian
    Wu, Qiang
    Ganesan, A.
    Wen, Shijun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 15586 - 15605